AzTrials
AzTrials

Incisional HerniaPhase 3NCT04347642

Umbilical vs Paraumbilical Trocar Placement in Patients Undergoing Elective Laparoscopic Cholecystectomy

A Phase 3 study testing Umbilical port placement and Paraumbilical port placement in people with Incisional Hernia, run by Hospital General Universitario Elche at 2 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study will be to assess the incisional hernia rate of umbilical or paraumbilical port 12 months after laparoscopic cholecystectomy. Patients will be randomized into 2 groups: G1: 12mm Umbilical port will be inserted in the umbilical region, with open access and using a Hasson port G2: 12 mm… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Incisional Hernia
What is being tested?
Umbilical port placement and Paraumbilical port placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
2 sitesin 2 countries
Study dates
7 Jul 2020to 15 Sep 2021
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective laparoscopic cholecystectomy
  • Acceptance to participate in the study and sign of informed consent form

Who cannot join

  • A gallstone larger than 10mm observed at preoperative ultrasonography
  • Coexistence of umbilical hernia or previous umbilical hernioplasty
  • Previous laparotomy involving the umbilical region
  • Emergency surgery

Trial locations and contacts

2 sites in 2 countries.

Jaime Ruiz-Tovar contact

+34630534808

jruiztovar@gmail.com

Carolina LLavero contact

649593020

carolinallavero@gmail.com

2 sites in 2 countries

Mexico1 site, 1 recruiting
  • Gilberto Gonzalez

    Guadalajara

    Gilberto Gonzalez, +52 33 3848 2100

    Recruiting

Other trials in Mexico

Spain1 site, 1 recruiting
  • Jaime Ruiz-Tovar

    Madrid, Introducir Provincia O Estado, 28002

    Jaime Ruiz-Tovar, +34630534808, jruiztovar@gmail.com

    Recruiting

Other trials in Spain

About this study

The aim of this study will be to assess the incisional hernia rate of umbilical or paraumbilical port 12 months after laparoscopic cholecystectomy.

Patients will be randomized into 2 groups:

  • G1: 12mm Umbilical port will be inserted in the umbilical region, with open access and using a Hasson port
  • G2: 12 mm paraumbilical port will be inserted laterally to the midline, with close access and using and optical port.

Incisional hernia at the level of this port insertion will be assessed by physical examination and, in case of doubst, by ultrasonography, 12 months after surgery.

Read the detailed description

The aim of this study will be to assess the incisional hernia rate of umbilical or paraumbilical port 12 months after laparoscopic cholecystectomy.

Patients will be randomized into 2 groups:

  • G1: 12mm Umbilical port will be inserted in the umbilical region, with open access and using a Hasson port. Pneumoperitoneum will be done by this Hasson port.
  • G2: 12 mm paraumbilical port will be inserted laterally to the midline, with close access and using and optical port, traversing the rectus abdominal muscle. Pneumoperitoneum will be previously done using a Veress needle.

Incisional hernia at the level of this port insertion will be assessed by physical examination and, in case of doubst, by ultrasonography, 12 months after surgery.

Being tested
Umbilical port placement, Paraumbilical port placement
Medical subject headings
Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Umbilical port placementProcedure or surgery

    The port will be inserted in the midline at the level of the umbilicus.

  • Paraumbilical port placementProcedure or surgery

    The port will be inserted 3-4cm laterally to the midline at the level of the umbilicus.

Study groups in NCT04347642
Study groupRoleWhat they receive
Umbilical portActive comparatorA Hasson port will be inserted at the level of the umbilicus,in the midline, traversing only aponeurotic layers.
Receives: Procedure: Umbilical port placement
Paraumbilical portExperimentalA bladeless 12mm port will be inserted lateral to the midline, traversing aponeurotic layers and rectus abdominis muscle.
Receives: Procedure: Paraumbilical port placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incisional hernia at the level of the trocar insertion

    The incisional hernia at the level of the umbilical or paraumbilial trocar insertion will be assessed by physical examination, or with ultrasonography in case of doubts.

    Measured: 12 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2020
  2. Study start7 Jul 2020
  3. Primary completion15 Sep 2021 (estimated)
  4. Study completion15 Sep 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04347642
Sponsor's protocol ID
Garcilaso 2020/1
Status last verified
Jul 2020
First submitted
12 Apr 2020
Last updated
9 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Umbilical port placement and Paraumbilical port placement in people with Incisional Hernia, run by Hospital General Universitario Elche at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Mexico, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jaime Ruiz-Tovar (+34630534808, jruiztovar@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incisional hernia at the level of the trocar insertion (time frame: 12 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in